missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. CD300c Rabbit anti-Human, Clone: 72, Novus Biologicals™
  7. 18237296

CD300c Rabbit anti-Human, Clone: 72, Novus Biologicals™

Rabbit Monoclonal Antibody

Brand:  Novus Biologicals NBP2-89991-100UL

 View more versions of this product

Product Code. 18237296

  • £429.00 / 100µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

CD300c Monoclonal specifically detects CD300c in Human samples. It is validated for ELISA, Sandwich ELISA Capture.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CD300c
Monoclonal
Unconjugated
0.2 um filtered solution in PBS
Rabbit
Protein A purified
RUO
10871
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
IgG
ELISA
72
ELISA 1:5000-1:10000, Sandwich ELISA Capture 1:250-1:2000
CD300c antigenCMRF35 antigen, CD300c molecule, CLM-6, CMRF-35, CMRF35 leukocyte immunoglobulin-like receptor, CMRF-35A, CMRF35A leukocyte immunoglobulin-like receptor, CMRF35ACMRF35A1, CMRF35CMRF35-A1, CMRF35-like molecule 6, IgSF16, IGSF16CD300 antigen-like family member C, Immunoglobulin superfamily member 16, LIR
Recombinant Human CD300c/LMIR2 Protein
100 μg
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.